Sun Pharma acquires Organon in $11.75 billion deal | Factae💰Sun Pharma acquires Organon in $11.75 billion deal
Indian pharmaceutical company Sun Pharma announces acquisition of U.S. drugmaker Organon for $11.75 billion in cash.
Published 11sem·1 sourceMajor·updated 11sem
The fact
The deal strengthens Sun Pharma's footprint in the global pharmaceutical market.
Sun Pharma shares surge following the announcement.
💰🔗Cross-sources — 1 source
Observed impact
Consolidation du secteur pharmaceutique
Renforcement de la position indienne en santé mondiale
IndeWorld map →Auto-synthesis from 1 media source · identified on April 26, 2026